Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Postmenopausal Women at High-Risk for Ovarian Cancer

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-08-0150
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Serum HE4 and Diagnosis of Ovarian Cancer in Postmenopausal Women With Adnexal Masses

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2020English

Chronic Medical Conditions and CA125 Levels Among Women Without Ovarian Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2018English

Use of a Symptom Index, CA125, and HE4 to Predict Ovarian Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2010English

Biomarkers and Algorithms for Diagnosis of Ovarian Cancer: CA125, HE4, RMI and ROMA, a Review

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

Predicting Circulating CA125 Levels Among Healthy Premenopausal Women

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Effects of Hormone Therapy on Serum Lipid Levels in Postmenopausal Korean Women

Journal of Menopausal Medicine
2015English

The Use of HE4, CA125 and CA72-4 Biomarkers for Differential Diagnosis Between Ovarian Endometrioma and Epithelial Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

Analysis of Serum Level of HE4 and CA125 Considering Selected Risk Factors Among Patients With Endometrioid Endometrial Cancer

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2016English

Serum HE4 Levels Combined With CE CT Imaging Improve the Management of Monitoring Women Affected by Epithelial Ovarian Cancer

Oncology Reports
MedicineCancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy